EarGenie MVP Performance Evaluation
NCT: NCT06406088 · TERMINATED
Brief Summary
This is a single-group clinical trial to evaluate the performance of the EarGenie minimum viable product (MVP) in normal hearing infants. The EarGenie MVP tests for detection and discrimination of sounds will be administered, and the sensitivity and specificity of the tests will be estimated for a range of sound levels (detection) and speech sound contrasts (discrimination).
Frequently Asked Questions
What is EarGenie MVP Performance Evaluation?
EarGenie MVP Performance Evaluation is a clinical trial registered under NCT06406088. Current status: TERMINATED.
What is the status of NCT06406088?
The current status of NCT06406088 (EarGenie MVP Performance Evaluation) is: TERMINATED.
When did EarGenie MVP Performance Evaluation start?
EarGenie MVP Performance Evaluation started on 2024-08-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.